goeg logo goeg logo ppri logo ppri logo

Summer School

Pharmaceutical Pricing and Reimbursement Policies

Monday, 29 August 2016 – Friday, 2 September 2016

Vienna, Austria

Venue:

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
Stubenring 6
1010 Vienna, Austria

Organisers:

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Department of Health Economics at the Austrian Public Health Institute (Gesundheit Österreich GmbH)

in collaboration with the

World Health Organization, Regional Office for Europe

Course language: English, Russian (with simultaneous translation)

Contact: whocc@goeg.at

Group Picture

Between Monday, 29 August and Friday, 02 September 2016 33 participants of public and non-for profit institutions working in the field of pricing and reimbursement of medicines of 18 different countries attended the first Summer School on Pharmaceutical Pricing and Reimbursement Policies in Vienna.

The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies at the Austrian Public Health Institute (Gesundheit Österreich Gmbh) and the World Health Organization (WHO), Regional Office for Europe organised the five-day training course. Representatives of these organisations and of the EuroScan International Network provided information on pharmaceutical policies, focussed on pricing and reimbursement of medicines, medicine price surveys, policies for high-priced medicines and generics, Horizon Scanning, patents and trade agreements.

Focussing on the European region, the summer school provided lectures, hands-on training, case studies and poster sessions on the main topics. Furthermore study visits to relevant institutions in Vienna were offered.

On Wednesday 31 August a public panel discussion titled “Access to new high-priced medicines in Europe – Challenges and solutions” was organised, which received high interest by Austrian stakeholders. Panellists were Clemens Auer, Head of Section I in the Austrian Federal Ministry of Health and Women’s Affairs (BMGF); Richard Bergström, General Director of European Federation of Pharmaceutical Industries and Associations (EFPIA); Peter Beyer, World Health Organization (WHO); Yannis Natsis; European Public Health Alliance (EPHA) Policy Coordinator for universal access & affordable medicines; Josef Probst, General director of the Main Association of Austrian Social Security Institutions (HVB); and Dr Sabine Vogler, Head of WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies at the Austrian Public Health Institute (GÖG).

Gruppe
More pictures can be found in the Gallery

Course language was English with simultaneous translation into Russian.